Overview of Dr. Daghistani
Dr. Doured Daghistani is a pediatric hematologist/oncologist in Miami, FL and is affiliated with multiple hospitals in the area, including Baptist Hospital of Miami, South Miami Hospital, Homestead Hospital, and Nicklaus Children's Hospital. He received his medical degree from Damascus University Faculty of Medicine and has been in practice 36 years. He is one of 28 doctors at Nicklaus Children's Hospital who specialize in Pediatric Hematology & Oncology. He has more than 10 publications and over 300 citings.
Office
Baptist Health Miami Cancer Institute
8900 N Kendall Dr
Miami, FL 33176
Education & Training
- University of Miami/Jackson Health SystemResidency, Pediatrics, 1983 - 1988
- Damascus University Faculty of MedicineClass of 1981
Certifications & Licensure
- FL State Medical License 1985 - 2027
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Top Doctors:South Florida Castle Connolly, 2012
- Top Doctors: Florida Castle Connolly, 2000
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
- Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsSafety and pharmacokinetics of ONC201 (dordaviprone) administered two consecutive days per week in pediatric patients with H3 K27M-mutant glioma.Yazmin Odia, Carl Koschmann, Nicholas A Vitanza, Peter de Blank, Dolly Aguilera
Neuro-Oncology. 2024-05-03 - 2 citationsSelective DRD2 antagonist and ClpP agonist ONC201 in a recurrent non-midline H3 K27M-mutant glioma cohort.Yazmin Odia, Matthew D Hall, Timothy Francis Cloughesy, Patrick Y Wen, Isabel Arrillaga-Romany
Neuro-Oncology. 2024-05-03 - 38 citationsClinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M Waszak, Stefan R Sweha
Cancer Discovery. 2023-11-01
Press Mentions
- Two Haitian Boys Are Battling Cancer. 700 Miles May Make All the DifferenceNovember 19th, 2018
- Your Child Has Been Diagnosed with Cancer. Don’t Panic. Smart Treatments AboundJuly 27th, 2018
- Radiation Therapy in Children with Cancer Is UM SpecialtyJuly 24th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: